Literature DB >> 25411775

Trends in mortality from COPD among adults in the United States.

Earl S Ford1.   

Abstract

BACKGROUND: COPD imposes a large public health burden internationally and in the United States. The objective of this study was to examine trends in mortality from COPD among US adults from 1968 to 2011.
METHODS: Data from the National Vital Statistics System from 1968 to 2011 for adults aged ≥ 25 years were accessed, and trends in mortality rates were examined with Joinpoint analysis.
RESULTS: Among all adults, age-adjusted mortality rate rose from 29.4 per 100,000 population in 1968 to 67.0 per 100,000 population in 1999 and then declined to 63.7 per 100,000 population in 2011 (annual percentage change [APC] 2000-2011, -0.2%; 95% CI, -0.6 to 0.2). The age-adjusted mortality rate among men peaked in 1999 and then declined (APC 1999-2011, -1.1%; 95% CI, -1.4 to -0.7), whereas the age-adjusted mortality rate among women increased from 2000 to 2011, peaking in 2008 (APC 2000-2011, 0.4%; 95% CI, 0.0-0.9). Despite a narrowing of the sex gap, mortality rates in men continued to exceed those in women. Evidence of a decline in the APC was noted for black men (1999-2011, -1.5%; 95% CI, -2.1 to -1.0) and white men (1999-2011, -0.9%; 95% CI, -1.3 to -0.6), adults aged 55 to 64 years (1989-2011, -1.0%; 95% CI, -1.2 to -0.8), and adults aged 65 to 74 years (1999-2011, -1.2%; 95% CI, -1.6 to -0.9).
CONCLUSIONS: In the United States, the mortality rate from COPD has declined since 1999 in men and some age groups but appears to be still rising in women, albeit at a reduced pace.

Entities:  

Mesh:

Year:  2015        PMID: 25411775      PMCID: PMC4587987          DOI: 10.1378/chest.14-2311

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates.

Authors:  R N Anderson; A M Miniño; D L Hoyert; H M Rosenberg
Journal:  Natl Vital Stat Rep       Date:  2001-05-18

3.  Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009.

Authors:  Lara J Akinbami; Xiang Liu
Journal:  NCHS Data Brief       Date:  2011-06

4.  Death certificate reporting of confirmed airways obstructive disease.

Authors:  A E Camilli; D R Robbins; M D Lebowitz
Journal:  Am J Epidemiol       Date:  1991-04-15       Impact factor: 4.897

5.  The causes of death in chronic airway obstruction. I. The unreliability of death certificates and routine autopsies.

Authors:  R S Mitchell; S H Walker; G W Silvers; G Dart; J C Maisel
Journal:  Am Rev Respir Dis       Date:  1968-10

6.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

7.  Trends in the leading causes of death in the United States, 1970-2002.

Authors:  Ahmedin Jemal; Elizabeth Ward; Yongping Hao; Michael Thun
Journal:  JAMA       Date:  2005-09-14       Impact factor: 56.272

8.  Sex differences in COPD and lung cancer mortality trends--United States, 1968-1999.

Authors:  Neely Kazerouni; C J Alverson; Stephen C Redd; Joshua A Mott; David M Mannino
Journal:  J Womens Health (Larchmt)       Date:  2004 Jan-Feb       Impact factor: 2.681

9.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

Authors:  David M Mannino; David M Homa; Lara J Akinbami; Earl S Ford; Stephen C Redd
Journal:  MMWR Surveill Summ       Date:  2002-08-02

10.  Age-period-cohort analysis of chronic obstructive pulmonary disease mortality in Japan, 1950-2004.

Authors:  Truong-Minh Pham; Kotaro Ozasa; Tatsuhiko Kubo; Yoshihisa Fujino; Ritsu Sakata; Eric J Grant; Shinya Matsuda; Takesumi Yoshimura
Journal:  J Epidemiol       Date:  2012-03-10       Impact factor: 3.211

View more
  17 in total

1.  Deaths from Nonmalignant Respiratory Disease in Styrene-Exposed Workers: Does Obliterative Bronchiolitis Contribute to Mortality?

Authors:  Randall J Nett; Nicole T Edwards; Avima M Ruder; Stephen J Bertke; Isna Keumala; Jean Cox-Ganser; Kristin J Cummings
Journal:  Ann Am Thorac Soc       Date:  2017-05

2.  Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

Authors:  Robert A Wise; Russell A Acevedo; Antonio R Anzueto; Nicola A Hanania; Fernando J Martinez; Jill A Ohar; Donald P Tashkin
Journal:  Chronic Obstr Pulm Dis       Date:  2016-11-15

3.  A Comparison of Variances in Age Cohorts to Understand Longevity in African Americans.

Authors:  Keith E Whitfield; Sarah Forrester; Roland J Thorpe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-11-13       Impact factor: 6.053

Review 4.  Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.

Authors:  Uta Griesenbach; Eric W F W Alton
Journal:  F1000Prime Rep       Date:  2015-05-27

5.  Neurological Sequelae and Clinical Outcomes After Lung Transplantation.

Authors:  Patrick J Smith; Gregory L Stonerock; Krista K Ingle; Caroline K Saulino; Benson Hoffman; Brian Wasserman; James A Blumenthal; Scott M Palmer; Jacob A Klapper; Matthew G Hartwig; Valentine R Esposito; Laurie D Snyder
Journal:  Transplant Direct       Date:  2018-03-19

6.  Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

Authors:  Dave Singh; Jadwiga A Wedzicha; Salman Siddiqui; Alberto de la Hoz; Wenqiong Xue; Helgo Magnussen; Marc Miravitlles; James D Chalmers; Peter M A Calverley
Journal:  Respir Res       Date:  2020-09-17

7.  Trends and area variations in Potentially Preventable Admissions for COPD in Spain (2002-2013): a significant decline and convergence between areas.

Authors:  Julián Librero; Berta Ibañez-Beroiz; Salvador Peiró; M Ridao-López; Clara L Rodríguez-Bernal; Francisco J Gómez-Romero; Enrique Bernal-Delgado
Journal:  BMC Health Serv Res       Date:  2016-08-09       Impact factor: 2.655

8.  The Association Between Neighborhood Socioeconomic Disadvantage and Chronic Obstructive Pulmonary Disease.

Authors:  Panagis Galiatsatos; Han Woo; Laura M Paulin; Amy Kind; Nirupama Putcha; Amanda J Gassett; Christopher B Cooper; Mark T Dransfield; Trisha M Parekh; Gabriela R Oates; R Graham Barr; Alejandro P Comellas; Meilan K Han; Stephen P Peters; Jerry A Krishnan; Wassim W Labaki; Meredith C McCormack; Joel D Kaufman; Nadia N Hansel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-05

9.  Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies.

Authors:  Roland Buhl; Dave Singh; Alberto de la Hoz; Wenqiong Xue; Gary T Ferguson
Journal:  Adv Ther       Date:  2020-05-27       Impact factor: 3.845

10.  Airway epithelial cells exposed to wildfire smoke extract exhibit dysregulated autophagy and barrier dysfunction consistent with COPD.

Authors:  Eugene Roscioli; Rhys Hamon; Susan E Lester; Hubertus P A Jersmann; Paul N Reynolds; Sandra Hodge
Journal:  Respir Res       Date:  2018-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.